CRISPR, Gene Editing & DNA-Repair Antibodies
Evaluate DNA-damage signaling repair-pathway activation and editing outcomes with antibodies targeting Cas9, RAD51, BRCA2 DNA-PK, ATM, ATR and other key genome-stability proteins.
Catalog #1: bsm-70350M
WB
FCM
IP
Reactivity: Human
Conjugate: Unconjugated